ITDC
India is proposing an immediate production halt for medicines that fail specified quality tests, alongside new checks on who releases a batch for sale and what happens when contamination is found on the factory floor.
The Health Ministry’s proposal, announced on 4 November, would require the relevant licensing authority to suspend the manufacturing licence for the drug concerned immediately upon receiving a government analyst’s report identifying a specified quality failure. These cover active-ingredient content, drug dissolution, related substances, impurities and sterility. The ministry says the present show-cause procedure can leave a gap between a failed test and regulatory action, while the medicine remains in circulation.
Restarting manufacture would require more than a reply to the regulator. The company would have to identify the cause and implement corrective and preventive action, verified by the licensing authority. The analyst’s report would also reach the central drugs controller, the relevant state regulator, manufacturer and marketer.
A separate proposal announced on 3 November tackles an earlier decision: who clears each batch for distribution. Manufacturers would designate a qualified, experienced person and keep prescribed release records. The ministry says licences already identify manufacturing and testing staff, but do not specifically identify the authorised batch-release person.
The third change concerns sterile medicines. A 4 November proposal would align Grade A clean-area monitoring with WHO guidance, under which any microbial growth prompts investigation. It addresses the environment where exposed products and sterilised components are handled.
These are proposals under consultation, not new rules already in force. The proposed suspension is tied to the drug and specified test findings; it is not a blanket closure of every product made by a company.
The ministry has invited objections and suggestions. The suspension proposal allows 30 days for comments from the date the draft Gazette is made available to the public.
Hashtags: #Health #NewDelhi #Failed #Drug #Test #Faster #LifeकीPulse #Halt #India #Proposes
